1. Home
  2. CELU vs MAGH Comparison

CELU vs MAGH Comparison

Compare CELU & MAGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MAGH
  • Stock Information
  • Founded
  • CELU 2016
  • MAGH 2012
  • Country
  • CELU United States
  • MAGH Singapore
  • Employees
  • CELU N/A
  • MAGH N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MAGH Engineering & Construction
  • Sector
  • CELU Health Care
  • MAGH Industrials
  • Exchange
  • CELU Nasdaq
  • MAGH Nasdaq
  • Market Cap
  • CELU 56.9M
  • MAGH 51.8M
  • IPO Year
  • CELU N/A
  • MAGH 2025
  • Fundamental
  • Price
  • CELU $2.00
  • MAGH $1.67
  • Analyst Decision
  • CELU Strong Buy
  • MAGH
  • Analyst Count
  • CELU 1
  • MAGH 0
  • Target Price
  • CELU $6.00
  • MAGH N/A
  • AVG Volume (30 Days)
  • CELU 167.1K
  • MAGH 210.5K
  • Earning Date
  • CELU 12-05-2025
  • MAGH 11-08-2025
  • Dividend Yield
  • CELU N/A
  • MAGH N/A
  • EPS Growth
  • CELU N/A
  • MAGH N/A
  • EPS
  • CELU N/A
  • MAGH 0.00
  • Revenue
  • CELU $44,590,000.00
  • MAGH $11,752,129.00
  • Revenue This Year
  • CELU N/A
  • MAGH N/A
  • Revenue Next Year
  • CELU $76.00
  • MAGH N/A
  • P/E Ratio
  • CELU N/A
  • MAGH $1,777.24
  • Revenue Growth
  • CELU 4.45
  • MAGH N/A
  • 52 Week Low
  • CELU $1.00
  • MAGH $0.99
  • 52 Week High
  • CELU $5.22
  • MAGH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • CELU 42.49
  • MAGH N/A
  • Support Level
  • CELU $1.94
  • MAGH N/A
  • Resistance Level
  • CELU $2.06
  • MAGH N/A
  • Average True Range (ATR)
  • CELU 0.13
  • MAGH 0.00
  • MACD
  • CELU 0.02
  • MAGH 0.00
  • Stochastic Oscillator
  • CELU 16.47
  • MAGH 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About MAGH Magnitude International Ltd Ordinary Shares

Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.

Share on Social Networks: